SCHEMBL1573769

SCHEMBL1573769

O=C(O)N1C2COCC1CC(Nc1ccccc1[N+](=O)[O-])C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.48
HCAR3 P49019 3/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 5/20 0.41
GAA P10253 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
CASP7 P55210 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573767 1.00 MAPK1 (0.48) MAPK1HCAR3RAB9ANPC1MEN1
SCHEMBL1573863 0.90 MAPK1 (0.53) MAPK1HCAR3RAB9ANPC1MEN1
SCHEMBL1573866 0.90 MAPK1 (0.53) MAPK1HCAR3RAB9ANPC1MEN1
SCHEMBL7236134 0.90 MAPK1 (0.53) MAPK1HCAR3RAB9ANPC1MEN1
SCHEMBL1573772 0.81 MAPK1 (0.61) MAPK1RAB9AMEN1KMT2ANPSR1
SCHEMBL22716655 0.80 MAPK1 (0.53) MAPK1HCAR3RAB9ANPC1MEN1
SCHEMBL31192586 0.80 MAPK1 (0.53) MAPK1HCAR3RAB9ANPC1MEN1
SCHEMBL1573922 0.80 KDM4E (0.44) MAPK1RAB9ANPC1GAAMAPT
SCHEMBL1573923 0.80 KDM4E (0.44) MAPK1RAB9ANPC1GAAMAPT
SCHEMBL31196591 0.79 MAPK1 (0.53) MAPK1HCAR3RAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140085-B1 AZABICYCLOALKANES AS CCR5 MODULATORS PHIVCO UK LTD (GB) 2011-04-13 EP disclosed
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed